WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996004302) NOVEL TUMOR MARKER FOR LUNG CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/004302    International Application No.:    PCT/EP1995/002962
Publication Date: 15.02.1996 International Filing Date: 26.07.1995
Chapter 2 Demand Filed:    26.02.1996    
IPC:
A61K 38/00 (2006.01), A61K 39/00 (2006.01), A61K 47/48 (2006.01), A61K 51/10 (2006.01), C07K 14/47 (2006.01), C07K 16/18 (2006.01), C07K 16/30 (2006.01), G01N 33/574 (2006.01)
Applicants: F. HOFFMANN-LA ROCHE AG [CH/CH]; 124 Grenzacherstrasse, CH-4002 Basle (CH) (For All Designated States Except US).
COCCIOLO, Maria, Gabriella [IT/IT]; (IT) (For US Only).
GRASSI, Cinzia [IT/IT]; (IT) (For US Only).
MAURER, Andreas [CH/CH]; (CH) (For US Only).
PIZZORNO, Beatrice [IT/IT]; (IT) (For US Only)
Inventors: COCCIOLO, Maria, Gabriella; (IT).
GRASSI, Cinzia; (IT).
MAURER, Andreas; (CH).
PIZZORNO, Beatrice; (IT)
Agent: COTTONG, Norbert, A.; P.O. Box 3255, CH-4002 Basle (CH)
Priority Data:
94202268.2 05.08.1994 EP
Title (EN) NOVEL TUMOR MARKER FOR LUNG CANCER
(FR) NOUVEAU MARQUEUR TUMORAL DU CANCER DU POUMON
Abstract: front page image
(EN)The invention provides a new tumor marker for lung cancer, which is derived from a lung cancer antigen which is a glycoprotein recognized by a monoclonal antibody selected from the group consisting of monoclonal antibodies P14B4 (DSM ACC2170) and P6F7 (DSM ACC2171), a monoclonal antibody recognizing this lung cancer antigen, a reagent and a test kit for diagnosis of lung cancer, an imaging agent, an immunotoxin and a vaccine, which contain such a monoclonal antibody, as well as methods for diagnosing lung cancer which use such a monoclonal antibody.
(FR)L'invention concerne un nouveau marqueur tumoral du cancer du poumon, qui provient d'un antigène de cancer du poumon constitué par une glycoprotéine reconnue par un anticorps monoclonal choisi dans le groupe des anticorps monoclonaux P14B4 (DSM ACC2170) et P6F7 (DSM ACC2171). Elle concerne aussi un anticorps monoclonal reconnaissant cet antigène de cancer du poumon, un réactif et une trousse d'essai destinés au diagnostic du cancer du poumon, un agent d'imagerie, une immunotoxine et un vaccin, qui contient cet anticorps monoclonal, ainsi que des procédés permettant de diagnostiquer le cancer du poumon et qui impliquent d'utiliser cet anticorps monoclonal.
Designated States: CA, JP, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)